Precipio PE Ratio 2012-2025 | PRPO
Current and historical p/e ratio for Precipio (PRPO) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Precipio PE ratio as of January 12, 2026 is 0.00.
| Precipio PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-01-13 | 25.71 | 0.00 | |
| 2025-09-30 | 17.79 | $-0.82 | 0.00 |
| 2025-06-30 | 11.04 | $-1.19 | 0.00 |
| 2025-03-31 | 6.27 | $-2.07 | 0.00 |
| 2024-12-31 | 5.54 | $-2.94 | 0.00 |
| 2024-09-30 | 6.70 | $-1.83 | 0.00 |
| 2024-06-30 | 5.19 | $-2.45 | 0.00 |
| 2024-03-31 | 6.70 | $-3.42 | 0.00 |
| 2023-12-31 | 6.50 | $-4.56 | 0.00 |
| 2023-09-30 | 5.61 | $-7.44 | 0.00 |
| 2023-06-30 | 7.80 | $-9.20 | 0.00 |
| 2023-03-31 | 13.28 | $-9.20 | 0.00 |
| 2022-12-31 | 11.03 | $-10.60 | 0.00 |
| 2022-09-30 | 16.08 | $-10.40 | 0.00 |
| 2022-06-30 | 21.20 | $-9.20 | 0.00 |
| 2022-03-31 | 27.00 | $-10.20 | 0.00 |
| 2021-12-31 | 31.60 | $-7.80 | 0.00 |
| 2021-09-30 | 56.40 | $-6.00 | 0.00 |
| 2021-06-30 | 72.60 | $-8.60 | 0.00 |
| 2021-03-31 | 46.20 | $-9.80 | 0.00 |
| 2020-12-31 | 41.40 | $-23.80 | 0.00 |
| 2020-09-30 | 49.00 | $-33.40 | 0.00 |
| 2020-06-30 | 28.40 | $-35.40 | 0.00 |
| 2020-03-31 | 14.00 | $-52.40 | 0.00 |
| 2019-12-31 | 41.00 | $-46.40 | 0.00 |
| 2019-09-30 | 52.20 | $-105.80 | 0.00 |
| 2019-06-30 | 67.60 | $-150.58 | 0.00 |
| 2019-03-31 | 37.50 | $-174.55 | 0.00 |
| 2018-12-31 | 46.20 | $-305.88 | 0.00 |
| 2018-09-30 | 118.56 | $-236.88 | 0.00 |
| 2018-06-30 | 110.34 | $-593.70 | 0.00 |
| 2018-03-31 | 161.16 | $-5,151.43 | 0.00 |
| 2017-12-31 | 360.00 | $-5,640.81 | 0.00 |
| 2017-09-30 | 648.00 | $-5,640.81 | 0.00 |
| 2017-06-30 | 2700.00 | $-5,953.37 | 0.00 |
| 2017-03-31 | 5057.50 | $-1,800.90 | 0.00 |
| 2016-12-31 | 2557.55 | $-2,611.31 | 0.00 |
| 2016-09-30 | 2537.75 | $-2,611.31 | 0.00 |
| 2016-06-30 | 4949.51 | $-6,843.43 | 0.00 |
| 2016-03-31 | 5251.88 | $-9,094.55 | 0.00 |
| 2015-12-31 | 9629.05 | $-10,895.45 | 0.00 |
| 2015-09-30 | 8307.97 | $-17,828.92 | 0.00 |
| 2015-06-30 | 15028.50 | $-13,326.67 | 0.00 |
| 2015-03-31 | 12958.70 | $-15,757.89 | 0.00 |
| 2014-12-31 | 18088.20 | $-17,918.97 | 0.00 |
| 2014-09-30 | 33926.60 | $-11,435.72 | 0.00 |
| 2014-06-30 | 33656.60 | $-17,471.34 | 0.00 |
| 2014-03-31 | 41215.90 | $-15,581.69 | 0.00 |
| 2013-12-31 | 49133.20 | $-14,502.88 | 0.00 |
| 2013-09-30 | 41034.30 | $-17,295.57 | 0.00 |
| 2013-06-30 | 43194.00 | $-15,133.63 | 0.00 |
| 2013-03-31 | 42654.00 | $-12,971.68 | 0.00 |
| 2012-12-31 | 65870.80 | $-14,052.65 | 0.00 |
| 2012-09-30 | 102586.00 | $-10,809.73 | 0.00 |
| 2012-06-30 | 97186.50 | $-9,728.76 | 0.00 |
| 2012-03-31 | 129582.00 | $-22,700.44 | 0.00 |
| 2011-12-31 | 139301.00 | $-23,781.41 | 0.00 |
| 2011-09-30 | 139301.00 | $-25,943.36 | 0.00 |
| 2011-06-30 | 188974.00 | $-24,862.38 | 0.00 |
| 2011-03-31 | 95026.70 | $-12,971.68 | 0.00 |
| 2010-12-31 | 71270.00 | $-7,566.81 | 0.00 |
| 2010-09-30 | 43194.00 | $-5,404.87 | 0.00 |
| 2010-06-30 | 52912.60 | $-4,323.89 | 0.00 |
| 2010-03-31 | 92435.10 | $-3,242.92 | 0.00 |
| 2009-12-31 | 74509.60 | $-4,323.89 | 0.00 |
| 2009-09-30 | 75589.50 | $-4,323.89 | 0.00 |
| 2009-06-30 | 43194.00 | $-4,323.90 | 0.00 |
| 2009-03-31 | 36714.90 | $-3,242.93 | 0.00 |
| 2008-12-31 | 47513.40 | $-1,080.98 | 0.00 |
| 2008-09-30 | 64791.00 | $-1,080.98 | 0.00 |
| 2008-06-30 | 86387.90 | $-3,242.92 | 0.00 |
| 2008-03-31 | 52912.60 | $-3,242.92 | 0.00 |
| 2007-12-31 | 58311.90 | $-5,404.86 | 0.00 |
| 2007-09-30 | 77749.20 | $-7,566.80 | 0.00 |
| 2007-06-30 | 74509.60 | $-7,566.80 | 0.00 |
| 2007-03-31 | 77749.20 | $-8,647.78 | 0.00 |
| 2006-12-31 | 48593.20 | $-7,566.82 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.046B | $0.019B |
| Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.335B | 44.34 |
| Tempus AI (TEM) | United States | $12.322B | 0.00 |
| Doximity (DOCS) | United States | $8.258B | 34.00 |
| Hims & Hers Health (HIMS) | United States | $7.362B | 59.89 |
| IRhythm Technologies (IRTC) | United States | $5.445B | 0.00 |
| Hinge Health (HNGE) | United States | $3.816B | 0.00 |
| Privia Health (PRVA) | United States | $2.881B | 180.15 |
| Inspire Medical Systems (INSP) | United States | $2.816B | 46.60 |
| Heartflow (HTFL) | United States | $2.707B | 0.00 |
| 10x Genomics (TXG) | United States | $2.506B | 0.00 |
| Omnicell (OMCL) | United States | $2.297B | 46.96 |
| Azenta (AZTA) | United States | $1.726B | 70.83 |
| Enovis (ENOV) | United States | $1.541B | 8.09 |
| Schrodinger (SDGR) | United States | $1.373B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.364B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.079B | 0.00 |
| Phreesia (PHR) | United States | $1.033B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.870B | 0.00 |
| Talkspace (TALK) | United States | $0.661B | 133.00 |
| Standard BioTools (LAB) | United States | $0.581B | 0.00 |
| Claritev (CTEV) | United States | $0.528B | 0.00 |
| Evolent Health (EVH) | United States | $0.463B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.387B | 0.00 |
| Carlsmed (CARL) | United States | $0.384B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.348B | 0.00 |
| TruBridge (TBRG) | United States | $0.328B | 15.06 |
| Senseonics Holdings (SENS) | United States | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.281B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.273B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.204B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.174B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.173B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.162B | 0.00 |
| CareCloud (CCLD) | United States | $0.125B | 6.84 |
| Outset Medical (OM) | United States | $0.101B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| HeartBeam (BEAT) | United States | $0.088B | 0.00 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| American Well (AMWL) | United States | $0.081B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.068B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.043B | 0.00 |
| 111 (YI) | China | $0.032B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.021B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.014B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |